Skip to main content
Supplement ScienceSupplementScience

Types of Bromelain: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Enteric-Coated TabletsHighSystemic anti-inflammatory — protects enzymes from stomach acid for blood absorption
Capsules (standard)ModerateGeneral use — some enzyme loss in stomach; take on empty stomach to reduce degradation
PowderLow-ModerateDigestive support — aids protein digestion when taken with meals

Enteric-Coated Tablets

Bioavailability: High. Best for: Systemic anti-inflammatory — protects enzymes from stomach acid for blood absorption.

Capsules (standard)

Bioavailability: Moderate. Best for: General use — some enzyme loss in stomach; take on empty stomach to reduce degradation.

Powder

Bioavailability: Low-Moderate. Best for: Digestive support — aids protein digestion when taken with meals.

Full Bromelain Guide

References

  1. ReviewBrien S, Lewith G, Walker A, et al. (2004). Bromelain as a treatment for osteoarthritis: a review of clinical studies. Evidence-Based Complementary and Alternative Medicine. DOI PubMed
  2. RCTBraun JM, Schneider B, Beuth HJ (2005). Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In Vivo. PubMed
  3. RCTAkhtar NM, Naseer R, Farooqi AZ, et al. (2004). Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee. Clinical Rheumatology. DOI PubMed
  4. Günay UB, Tanin MK, Demiröz A (2026). Efficacy and Safety of Bromelain-Based Enzymatic Debridement for Chronic Wounds: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. DOI PubMed
  5. De Freitas LR, Udoma-Udofa OC, Reginato PH, Mitsui HC, et al. (2025). Bromelain-Based Enzymatic Debridement Versus Standard of Care in Deep Burn Injuries: A Systematic Review and Meta-Analysis.. Journal of burn care & research : official publication of the American Burn Association. DOI PubMed
  6. Meta-analysisLeelakanok N, Petchsomrit A, Janurai T, Saechan C, et al. (2023). Efficacy and safety of bromelain: A systematic review and meta-analysis.. Nutrition and health. DOI PubMed
  7. Avadanei-Luca S, Moraru DC, Bulgaru-Iliescu AI, Tatar R, et al. (2026). Histopathological Changes Following Bromelain-Based Enzymatic Debridement (NexoBrid®): A Comprehensive Systematic Review of Preclinical and Clinical Evidence.. Medical sciences (Basel, Switzerland). DOI PubMed
Show 1 more reference
  1. Alves Nobre T, de Sousa AA, Pereira IC, Carvalho Pedrosa-Santos ÁM, et al. (2025). Bromelain as a natural anti-inflammatory drug: a systematic review.. Natural product research. DOI PubMed